Deutsches Nebennieren-Karzinom-Register - German Adrenocortical Carcinoma Registry
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 1,000
- 试验地点
- 2
- 主要终点
- Overall Survival
研究概览
简要总结
Basic objective of the German Adrenocortical Carcinoma Registry is to improve the care of patients with adrenocortical cancer. The registration of as many patients as possible helps to collect data for the prognosis and prospects of success regarding different treatment plans. This data will be taken into consideration for planning prospective studies. With this registry, the recruitment of patients for prospective studies will be significantly facilitated. In this way - and in cooperation with networks in other countries (e.g. in Italy and France) - a structure allowing systematic improvement of therapy will be developed.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Histologically confirmed diagnosis of adrenocortical carcinoma
排除标准
- 未提供
结局指标
主要结局
Overall Survival
时间窗: From date of diagnosis until the date of death from any cause (or last follow-up), whichever came first, assessed up to 100 months
overall survival is defined as the length of time from diagnosis or the start of treatment until death from any cause.
次要结局
未报告次要终点
研究者
Martin Fassnacht
Head of Endocrinology
University of Wuerzburg